- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 15, 2025 | 11.61M sh |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $438.58K |
| Long Term Debt | Q3 2025 · Jun 30, 2024 | $399.33K |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $4.34M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $3.79M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $4.44M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $3.85M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $9.74M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $25.44K |
| Total Assets | Q3 2025 · Mar 31, 2025 | $22.53M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $72.37K |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 994 sh |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 523 sh |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$675.15K |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | −$3.7M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$3.56M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | −$2.99M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | −$3.12M |
| Eps Diluted restated | Q3 2025 · Mar 31, 2024 | −$545.79 |
| Eps Diluted restated | Q3 2025 · Mar 31, 2024 | −$3,164.41 |
| Eps Basic restated | Q3 2025 · Mar 31, 2024 | −$545.79 |
| Eps Basic restated | Q3 2025 · Mar 31, 2024 | −$3,164.41 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $348.84K |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $1.06M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $65.45K |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $195.71K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$526.7K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$1.46M |
| Net Income | Q3 2025 · Dec 31, 2023 | −$584.38K |
| Net Income | Q3 2025 · Sep 30, 2023 | −$350.87K |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$420.87K |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$1.28M |